How has Assembly Biosciences's change in accrued liabilities changed year-over-year?

Assembly Biosciences's change in accrued liabilities decreased by 11.5% year-over-year, from -$4.56M to -$5.09M.

What does change in accrued liabilities mean?

Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.

Assembly Biosciences ASMB Change in Accrued Liabilities

Change in Accrued Liabilities at other companies

Arrowhead ResearchARWR

-$8.64M-132%

Avalo TherapeuticsAVTX

-$1.5M+12.1%

Vir Biotechnology, Inc.VIR

-$17.22M-196%

Maravai LifeSciences Holdings, Inc.MRVI

-$5.34M-390%

Viridian Therapeutics, Inc.VRDN

-$23.69M-48.9%

BridgeBio PharmaBBIO

-$37.48M-93.5%

Other financials

Income statement

See full

Revenue$8.2M-12.8%

Operating income-$11.4M-14.4%

Net income-$9.1M-3.0%

EPS (diluted)-$0.54+53.8%

Balance sheet

See full

Cash & equivalents$31.1M+32.9%

Total debt$2.5M-17.5%

Total equity$198.6M+632%

Total assets$235.5M+138%

Cash flow

See full

Operating cash flow-$22.1M+5.7%

CapEx$19.0K—

Free cash flow-$22.1M+5.6%

Valuation

See full

Market cap$480.77M+262%

Enterprise value$452.14M+302%

P/S6.8×+2.6×

Profitability

See full

Operating margin-116.8%-26.1pp

Net margin-103.6%-22.7pp

FCF margin-150%-231pp

Returns & leverage

See full

Return on equity-36.9%-15.1pp

Debt / equity0×-0.1×

Current ratio6.6×+4.6×

Where this comes from

Reported directly by Assembly Biosciences in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherAccruedLiabilities.

The official record: Assembly Biosciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Assembly Biosciences's change in accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Assembly Biosciences's change in accrued liabilities?: Assembly Biosciences (ASMB) reported change in accrued liabilities of -$5.09M in Q1 2026.
How has Assembly Biosciences's change in accrued liabilities changed year-over-year?: Assembly Biosciences's change in accrued liabilities decreased by 11.5% year-over-year, from -$4.56M to -$5.09M.
What does change in accrued liabilities mean?: Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.